These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 8631003

  • 1. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG, Jen J, Merlo A, Baylin SB.
    Cancer Res; 1996 Feb 15; 56(4):722-7. PubMed ID: 8631003
    [Abstract] [Full Text] [Related]

  • 2. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA.
    Cancer Res; 1995 Oct 15; 55(20):4531-5. PubMed ID: 7553622
    [Abstract] [Full Text] [Related]

  • 3. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 4. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells.
    Herzog CR, Soloff EV, McDoniels AL, Tyson FL, Malkinson AM, Haugen-Strano A, Wiseman RW, Anderson MW, You M.
    Oncogene; 1996 Nov 07; 13(9):1885-91. PubMed ID: 8934534
    [Abstract] [Full Text] [Related]

  • 5. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
    Schmid M, Sen M, Rosenbach MD, Carrera CJ, Friedman H, Carson DA.
    Oncogene; 2000 Nov 23; 19(50):5747-54. PubMed ID: 11126361
    [Abstract] [Full Text] [Related]

  • 6. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
    Iravani M, Dhat R, Price CM.
    Oncogene; 1997 Nov 20; 15(21):2609-14. PubMed ID: 9399648
    [Abstract] [Full Text] [Related]

  • 7. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors.
    Knapek DF, Serrano M, Beach D, Trono D, Walker CL.
    Cancer Res; 1995 Apr 15; 55(8):1607-12. PubMed ID: 7712460
    [Abstract] [Full Text] [Related]

  • 8. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.
    Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ, Baylin SB.
    Cancer Res; 1997 Mar 01; 57(5):837-41. PubMed ID: 9041182
    [Abstract] [Full Text] [Related]

  • 9. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T, Mizushima Y, Kashii T, Kobayashi M.
    Anticancer Res; 1998 Mar 01; 18(3A):1537-42. PubMed ID: 9673367
    [Abstract] [Full Text] [Related]

  • 10. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
    Malumbres M, Pérez de Castro I, Santos J, Fernández Piqueras J, Pellicer A.
    Oncogene; 1999 Jan 14; 18(2):385-96. PubMed ID: 9927195
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
    Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD, Yang CS.
    Clin Cancer Res; 1999 Oct 14; 5(10):2704-13. PubMed ID: 10537333
    [Abstract] [Full Text] [Related]

  • 12. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
    Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL.
    Cancer Res; 1997 Mar 01; 57(5):832-6. PubMed ID: 9041181
    [Abstract] [Full Text] [Related]

  • 13. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M, Xiong Y.
    Oncogene; 1996 Nov 07; 13(9):2033-8. PubMed ID: 8934552
    [Abstract] [Full Text] [Related]

  • 14. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S, Kantarjian HM, Manshouri T, Chan CY, Pierce S, Hays KJ, Cortes J, Thomas D, Estrov Z, Albitar M.
    Clin Cancer Res; 1999 Jul 07; 5(7):1855-61. PubMed ID: 10430092
    [Abstract] [Full Text] [Related]

  • 15. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
    Lubomierski N, Kersting M, Bert T, Muench K, Wulbrand U, Schuermann M, Bartsch D, Simon B.
    Cancer Res; 2001 Aug 01; 61(15):5905-10. PubMed ID: 11479232
    [Abstract] [Full Text] [Related]

  • 16. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
    Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB.
    Cancer Res; 1995 Oct 15; 55(20):4525-30. PubMed ID: 7553621
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.
    Malumbres M, Pérez de Castro I, Santos J, Meléndez B, Mangues R, Serrano M, Pellicer A, Fernández-Piqueras J.
    Oncogene; 1997 Mar 20; 14(11):1361-70. PubMed ID: 9178896
    [Abstract] [Full Text] [Related]

  • 18. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
    Kuerbitz SJ, Malandro J, Compitello N, Baylin SB, Graff JR.
    Cell Growth Differ; 1999 Jan 20; 10(1):27-33. PubMed ID: 9950215
    [Abstract] [Full Text] [Related]

  • 19. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP, Taylor JA, White CM, Anna CH, Barrett JC, Devereux TR.
    Clin Cancer Res; 1995 Jul 20; 1(7):687-90. PubMed ID: 9816033
    [Abstract] [Full Text] [Related]

  • 20. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
    Quesnel B.
    Bull Cancer; 1998 Sep 20; 85(9):747-54. PubMed ID: 9817058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.